180 Wealth Advisors LLC Grows Stock Holdings in Axon Enterprise, Inc $AXON

180 Wealth Advisors LLC increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 552.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,978 shares of the biotechnology company’s stock after acquiring an additional 3,368 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Axon Enterprise were worth $2,259,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in Axon Enterprise by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after buying an additional 376,904 shares during the last quarter. Jennison Associates LLC lifted its stake in Axon Enterprise by 53.8% during the third quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after purchasing an additional 330,213 shares during the last quarter. Vestor Capital LLC boosted its holdings in Axon Enterprise by 438,636.3% in the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock valued at $690,170,000 after purchasing an additional 833,409 shares in the last quarter. Norges Bank acquired a new position in Axon Enterprise in the second quarter valued at approximately $637,806,000. Finally, Northern Trust Corp increased its stake in Axon Enterprise by 1.6% in the third quarter. Northern Trust Corp now owns 743,926 shares of the biotechnology company’s stock valued at $533,871,000 after purchasing an additional 11,726 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Strong Software & Services momentum supports a higher-margin recurring revenue outlook—analyst write-ups highlight ~38% revenue growth and continued subscription expansion, which underpins long-term upside. Read More.
• Positive Sentiment: Earnings beat: Axon’s Feb. quarter topped estimates on EPS and revenue (revenue up ~38.5% YoY), reinforcing the growth narrative that many investors cite when valuing the stock. Read More.
• Positive Sentiment: Municipal procurement continues to drive hardware + software adoption—local grants (e.g., Decatur, IL) are cited as examples of steady demand for public-safety tech. Read More.
• Positive Sentiment: Institutional/coverage interest (features mentioning funds and “trending” status) can attract flows and boost liquidity, supporting the stock over time. Read More.
• Neutral Sentiment: Aggregator/“trending” articles raise awareness but are not direct fundamental catalysts; useful for retail/institutional interest but don’t change cash flows immediately. Read More.
• Neutral Sentiment: Short-interest data being reported as “0 shares” with NaN changes reads like a reporting error—treat as noise until exchanges/brokers clarify; not an actionable signal now.
• Negative Sentiment: Insider selling: Director Erika Nardini sold 198 shares (~$506.58 avg) and Director Jeri Williams sold 157 shares (~$490 avg) in mid‑March; while small in absolute dollars, these filings can dent sentiment. Read More. Read More.
• Negative Sentiment: Near-term skepticism: critical pieces noting a multi‑day losing streak and a sizable short-term market‑cap decline are amplifying caution and likely contributing to today’s pullback. Read More.

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the transaction, the insider directly owned 55,588 shares in the company, valued at approximately $29,740,135.88. The trade was a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeri Williams sold 157 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the sale, the director directly owned 1,159 shares of the company’s stock, valued at $567,910. The trade was a 11.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 23,855 shares of company stock valued at $13,299,928 in the last quarter. Corporate insiders own 5.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on AXON shares. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Craig Hallum reaffirmed a “buy” rating and issued a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Barclays cut their price target on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Piper Sandler reduced their price target on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Finally, UBS Group decreased their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $762.93.

Axon Enterprise Price Performance

AXON stock opened at $496.12 on Monday. The company has a market capitalization of $39.89 billion, a P/E ratio of 326.39, a PEG ratio of 10.59 and a beta of 1.46. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The business has a 50 day simple moving average of $519.47 and a 200-day simple moving average of $599.45. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business had revenue of $796.72 million for the quarter, compared to analysts’ expectations of $755.29 million. During the same period in the previous year, the company posted $2.08 EPS. The company’s quarterly revenue was up 38.5% on a year-over-year basis. As a group, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.